Company
Absci Corp (ABSI)
Standardized SEC financial data for Absci Corp — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001672688 · NASDAQ · Services-Commercial Physical & Biological Research.
Operating margin
-1000.0%
Net margin
-1000.0%
Revenue growth (YoY)
-38.2%
Return on equity
-60.8%
ROIC
-54.8%
Free cash flow
-$94.0M
Debt / equity
0.02×
Current ratio
6.57×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $4.8M | $4.8M | $5.7M | $5.7M | $4.5M | $2.8M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $71.7M | $279.9M | $76.8M | $89.7M | $58.2M | $21.1M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$11.0M | -$60.6M | -$81.3M | -$64.6M | -$72.4M | -$92.9M |
| Capital expenditures |
Get ABSI data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ABSI/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ABSI/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"